Industria Bucătăriei și Baiilor Mass-media de masă Informații despre Bucătărie și Baie
Israeli digital health startup OutSense was awarded a number of key innovation patents for IoT technology, foreign media reported on June 23. The technology gains life-saving medical insights by analyzing human excrement. Compania a depus o serie de trei brevete care acoperă elemente ale senzorului său de toaletă medicală.
The first OutSense patent is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet bowl to determine the optical signature of hidden blood in feces. Patents for this technology have been granted in the United States, Europa, Japonia și China. A second patent has been granted in Europe and applications are pending for this patent in other countries. It allows effective analysis of the spatial distribution of the many components of stool and traces of blood. Based on this analysis, Tehnologia OutSense poate identifica sursa de sânge de-a lungul tractului gastrointestinal. A third patent is pending for the technology, which detects urine dehydration components by analyzing urine and feces.
Potrivit CEO-ului OutSense, Yfat Scialom, he predicts that “cu explozia medicinei digitale. This kind of monitoring will become the norm.” OutSense says the technology, which has already been approved and is pending approval, will provide broad protection for a person’s health by non-invasively extracting hidden blood from feces and urine. Hidden blood is critical for detecting colorectal cancer, boli inflamatorii intestinale și infecții ale tractului urinar. Its solution includes a multispectral optical sensor, o sursă de lumină și un dispozitiv de ecranare autonom care include o conexiune WiFi. The device scans human feces and identifies the optical footprint of fecal and urine components. It sends the data to an artificial intelligence-based cloud analysis, which then provides signs of various diseases with great precision.
OutSense develops tools to diagnose abnormalities in human feces. Informații obținute din sângele prelevat, combinată cu o analiză suplimentară a timpului de la sângerare până la excreție, oferă detalii despre patologia sângerării. Its specific patterns can determine whether the bleeding is from a fissure or hemorrhoid, or from a polyp, tumor or from an ulcer. In early June, OutSense a anunțat că CommuniCare, o companie mare de asistență medicală cu mai mult de 90 medical facilities in the United States, va începe să-și piloteze tehnologia în acest an. Pe lângă acest pilot, OutSense plans to conduct clinical trials in Israel and Japan.